Report Overview

Global Peripheral Vascular Devices Market- Industry Trends & Forecast Report 2027

The global peripheral vascular devices market was worth USD 8.5 billion in 2020 and is further projected to reach USD 13.9 billion by the year 2027, growing at the CAGR of 7.5% during the forecast period (2021-2027). The rising prevalence of peripheral vascular disease, combined with the growing geriatric population, is driving up the demand for peripheral vascular devices. Furthermore, with the introduction of a number of improved products with broader applicability and an increase in diabetes patients across the globe, the market is expected to thrive during the forecast period.

Source: BlueWeave Consulting

Global Peripheral Vascular Devices Market- Overview

Peripheral Vascular Disease (PVD) is a medical illness in which the blood arteries become narrower, reducing the adequate flow of blood in the body. Except for the heart and brain vessels, peripheral vascular illnesses induce blockage or constriction of blood veins in the neck, arms, legs, or stomach. The blockage or limited blood supply in peripheral vessels raises the risk of stroke or heart attacks and, if ignored, can result in amputations. The treatment of peripheral vascular diseases calls for surgical procedures that are carried out using peripheral vascular devices. Plague modification devices, EVAR stent-grafts, angiography balloons, angioplasty catheters, IVC filters, etc., are some of the most commonly used peripheral vascular devices during a medical procedure.

Global Peripheral Vascular Devices Market Forecast and Trends

Growth Drivers

Rising Geriatric Population and Increasing Prevalence of Peripheral Vascular Diseases

The surge in the geriatric population due to improved life expectancy and better medical facilities has been a significant factor in the growth of the global peripheral vascular devices market. The older population is at a higher risk of developing peripheral vascular disorders, such as atherosclerosis and aneurysms. Furthermore, the prevalence of PVDs is increasing even among the younger population as a result of changing lifestyles and a lack of proper physical activity. As a result, the demand for surgeries is expanding, thereby propelling the growth of the global peripheral vascular devices market.

Development of Healthcare Infrastructure in Emerging Economies

With the development of healthcare infrastructure, the number of hospitals and other healthcare facilities is increasing. Also, the diagnosis of people will increase in the coming years and the accessibility of the patients suffering from peripheral vascular surgeries for the treatment will improve. This will help in fueling the demand for peripheral vascular devices as more and more patients are approaching hospitals for receiving surgeries. Furthermore, as minimally invasive surgeries gain popularity and people become more aware of them, the need for such peripheral vascular devices is witnessing an increasing demand.

Restraints

High Cost of the Peripheral Vascular Surgeries

Despite the fact that the geriatric population is growing, which is increasing the number of patients with peripheral vascular disease, surgery is still not available to everyone. According to the American Association for Vascular Surgery, the average cost of a patient's hospitalization for peripheral vascular surgery is roughly USD 27,000, which is quite expensive for a low-income patient. Therefore, many people with PVDs are hesitant to undergo surgery because of the hefty cost, which is stifling the growth of the global market.

Additionally, stringent regulatory procedures, equipment malfunctions, and recalls performances all impede the growth of the peripheral vascular devices market worldwide.

Impact of Covid-19 on Global Peripheral Vascular Devices Market

The Covid-19-induced pandemic has had a negative impact on the global peripheral vascular devices market. Because healthcare institutions are one of the most dangerous places for the virus to spread, patients deliberately avoided going to hospitals for the fear of being infected. For conducting medical procedures, such as surgeries, a patient has to undergo several clinical tests. However, in light of Covid-19, all elective and non-emergency procedures were postponed, resulting in a significant drop in demand for peripheral vascular devices. Furthermore, distribution and supply networks were halted, affecting the overall market growth.

Global Peripheral Vascular Devices Market - By Device-Type

Based on device types, the global peripheral vascular devices market is categorized into angioplasty balloons, angioplasty stents, catheters, stents grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other peripheral vascular devices. Among these, the stents segment dominates the market. Stents are said to be one of the most commonly used devices for the treatment of vascular diseases. The launch of innovative products in this segment such as bioabsorbable stents or others made up of advanced material are contributing significantly towards the growth of the stents market.

Global Peripheral Vascular Devices Market - Regional Insights

Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among all the regions, North America has the largest market share in both production and demand for peripheral vascular devices due to the rising adoption of minimally invasive surgeries, along with the increasing awareness of patients and the ever-growing healthcare expenditure in this region. These factors have enabled North America to maintain its dominance in the global peripheral vascular devices market. The Asia-Pacific region, on the other hand, is expected to emerge as a promising market in the forecast period as a result of the development of healthcare infrastructure and an increase in the number of patients affected by Peripheral Vascular Disease.

Competitive Landscape

The leading players in the global peripheral vascular devices market are Edward Lifesciences Corporation, Medtronic Inc., Abbott Laboratories, Jude Medical, Angioscore Inc., Teleflex Medical, Cook Group Inc., Cordis Corporation, Volcano Corporation, C.R.Bard, Terumo Corporation, Biosensors International Group, iVascular, Cardinal Health, Becton, Dickinson, and Company and other prominent players. The market is consolidated, with the largest industry participants controlling the majority of market share, resulting in intense competition. To keep ahead of the competition, the market players are consistently focusing on producing innovative products.

Recent Developments

• In April 2021, Endologix, a US-based medical device company, announced to have completed their acquisition of the PQ Bypass, Inc. which was a privately held medical technology company. Through this acquisition, Endologix aims to offer and expand innovative vascular devices and technologies, along with excelling in research and education in the field as well.

• In April 2021, Soundbite, a Canada-based medical devices company announced that they received the FDA approval for the Soundbite crossing system - Peripheral (SCS-P). The SCS-P is a tool that will help with the placement of guidewires or treatment devices during medical procedures.

Scope of the Report

By Type

Angioplasty Balloons

• Old/Normal Balloons
• Drug-Eluting Balloons
• Cutting And Scoring Balloons

Angioplasty Stents

• Drug-Eluting Stents
• Bare-Metal Stents

Catheters

• Angiography Catheters
• Guiding Catheters
• IVUS/OCT Catheters

Evar Stents Grafts

• Abdominal Aortic Aneurysm Stent Grafts
• Thoracic Aortic Aneurysm Stent Grafts

Inferior Vena Cava Filters

• Retrievable Filters
• Permanent Filters

Plaque Modification Devices

• Atherectomy Devices
• Thrombectomy Devices

Hemodynamic Flow Alteration Devices

• Embolic Protection Devices
• Chronic Total Occlusion (Cto) Devices

Other Peripheral Vascular Devices

• Guidewires
• Vascular Closure Devices
• Introducer Sheaths
• Balloon Inflation Devices

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Latin America (LATAM)
• Middle-East & Africa (MEA)

1. Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary and Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary and Secondary Sources

2.3. Breakdown of Primary Research Respondents

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Key Questionnaire asked during Primary Interviews

2.6. Key Primary Responses

2.7. Market Size Estimation

2.8. Assumption for the Study

2.9. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Peripheral Vascular Devices Market – Industry Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunity

4.1.4.   Challenges

4.2. Recent Developments / Technical Landscape

4.3. Regulatory Framework

4.4. Porter’s Five Forces Analysis

4.5. Value Chain Analysis

4.6. Strategic Outlook

5.    Global Peripheral Vascular Devices Market Overview

5.1. Market Estimates & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Type

5.2.1.1. Angioplasty Balloons

5.2.1.1.1.      Old/Normal Balloons

5.2.1.1.2.      Drug-Eluting Balloons

5.2.1.1.3.      Cutting And Scoring Balloons

5.2.1.2. Angioplasty Stents

5.2.1.2.1.      Drug-Eluting Stents

5.2.1.2.2.      Bare-Metal Stents

5.2.1.3. Catheters

5.2.1.3.1.      Angiography Catheters

5.2.1.3.2.      Guiding Catheters

5.2.1.3.3.      IVUS/OCT Catheters

5.2.1.4. Evar Stents Grafts

5.2.1.4.1.      Abdominal Aortic Aneurysm Stent Grafts

5.2.1.4.2.      Thoracic Aortic Aneurysm Stent Grafts

5.2.1.5. Inferior Vena Cava Filters

5.2.1.5.1.      Retrievable Filters

5.2.1.5.2.      Permanent Filters

5.2.1.6. Plaque Modification Devices

5.2.1.6.1.      Atherectomy Devices

5.2.1.6.2.      Thrombectomy Devices

5.2.1.7. Hemodynamic Flow Alteration Devices

5.2.1.7.1.       Embolic Protection Devices

5.2.1.7.2.      Chronic Total Occlusion (Cto) Devices

5.2.1.8. Other Peripheral Vascular Devices

5.2.1.8.1.      Guidewires

5.2.1.8.2.      Vascular Closure Devices

5.2.1.8.3.      Introducer Sheaths

5.2.1.8.4.      Balloon Inflation Devices

5.2.2.   By Region

5.2.2.1. North America

5.2.2.2. Europe

5.2.2.3. Asia-Pacific (APAC)

5.2.2.4. Latin America (LATAM)

5.2.2.5. Middle-East & Africa (MEA)

6.    North America Peripheral Vascular Devices Market Overview

6.1. Market Size and Forecast

6.1.1.   By Value (USD Million), 2017-2027

6.2. Market Share and Forecast

6.2.1.   By Device Type

6.2.2.   By Country

6.2.2.1. U.S.

6.2.2.2. Canada

7.    Europe Peripheral Vascular Devices Market Overview

7.1.     Market Size and Forecast

7.1.1.   By Value (USD Million), 2017-2027

7.2.     Market Share and Forecast

7.2.1.   By Device Type

7.2.2.   By Country

7.2.2.1.   Germany

7.2.2.2.   U.K.

7.2.2.3.   France

7.2.2.4.   Italy

7.2.2.5.   Spain

7.2.2.6.   Russia

7.2.2.7.   Netherlands

7.2.2.8.   Rest of Europe

8.    APAC Peripheral Vascular Devices Market Overview

8.1.     Market Size and Forecast

8.1.1.   By Value (USD Million), 2017-2027

8.2.     Market Share and Forecast

8.2.1.   By Device Type

8.2.2.   By Country

8.2.2.1.   China

8.2.2.2.   India

8.2.2.3.   Japan

8.2.2.4.   South Korea

8.2.2.5.   Rest of APAC

9.    LATAM Peripheral Vascular Devices Market Overview

9.1.     Market Size and Forecast

9.1.1.   By Value (USD Million), 2017-2027

9.2.     Market Share and Forecast

9.2.1.   By Device Type

9.2.2.   By Country

9.2.2.1.   Mexico

9.2.2.2.   Brazil

9.2.2.3.   Rest of LATAM

10. MEA Peripheral Vascular Devices Market Overview

10.1.   Market Size and Forecast

10.1.1.                By Value (USD Million), 2017-2027

10.2.   Market Share and Forecast

10.2.1.                By Device Type

10.2.2.                By Country

10.2.2.1.              Saudi Arabia

10.2.2.2.              UAE

10.2.2.3.              South Africa

10.2.2.4.              Turkey

10.2.2.5.              Rest of Europe

11.Competitive Landscape

11.1.1.                List of Key Players and Their Offerings

11.1.2.                Market Share / Ranking Analysis (2020)

11.1.3.                Competitive Benchmarking, By Operating Parameters

12.COVID-19 Impact

12.1.             Future Impact

12.2.             Key Developments during COVID-19

12.3.             Impact on Market

12.3.1.                Different Scenario

12.3.2.                Impact on Companies

12.4.             Regional Impact

13.Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

13.1.             Edward Lifesciences Corporation

13.2.             Medtronic Inc.

13.3.             Abbott Laboratories

13.4.             Jude Medical

13.5.             Angioscore Inc.

13.6.             Teleflex Medical

13.7.             Cook Group Inc.

13.8.             Cordis Corporation

13.9.             Volcano Corporation

13.10.          Boston Scientific Corporation

13.11.          Endologix

13.12.          Bayer

13.13.          Terumo Interventional Systems Inc.

13.14.          C.R.Bard

13.15.          Terumo Corporation

13.16.          Biosensors International Group

13.17.          iVascular

13.18.          Cardinal Health

13.19.          Becton, Dickinson, and Company

13.20.          Other prominent players

14.Key Strategic Recommendations

* Financial information of non-listed Companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

List of Figures

Fig: Global Peripheral Vascular Devices Segmentation

Fig: Global Peripheral Vascular Devices Value Chain Analysis,

Fig: Company Market Share Analysis, 2020

Fig: Global Peripheral Vascular Devices Size, By Value (USD Million), 2017-2027

Fig: Global Peripheral Vascular Devices Share (%), By Device Type, By Value, 2017-2027

Fig: Global Peripheral Vascular Devices Share (%), By Country, By Value, 2017-2027

Fig: North America Peripheral Vascular Devices Size, By Value (USD Million), 2017-2027

Fig: North America Peripheral Vascular Devices Share (%), By Device Type, By Value, 2017-2027

Fig: North America Peripheral Vascular Devices Share (%), By Country, By Value, 2017-2027

Fig: Europe Peripheral Vascular Devices Size, By Value (USD Million), 2017-2027

Fig: Europe Peripheral Vascular Devices Share (%), By Device Type, By Value, 2017-2027

Fig: Europe Peripheral Vascular Devices Share (%), By Country, By Value, 2017-2027

Fig: the Asia-Pacific Peripheral Vascular Devices Size, By Value (USD Million), 2017-2027

Fig: the Asia-Pacific Peripheral Vascular Devices Share (%), By Device Type, By Value, 2017-2027

Fig: Asia-Pacific Peripheral Vascular Devices Share (%), By Country, By Value, 2017-2027

Fig: Latin America Peripheral Vascular Devices Size, By Value (USD Million), 2017-2027

Fig: Latin America Peripheral Vascular Devices Share (%), By Device Type, By Value, 2017-2027

Fig: Latin America Peripheral Vascular Devices Share (%), By Country, By Value, 2017-2027

Fig: Middle East & Africa Peripheral Vascular Devices Size, By Value (USD Million), 2017-2027

Fig: Middle East & Africa Peripheral Vascular Devices Share (%), By Device Type, By Value, 2017-2027

Fig: Middle East & Africa Peripheral Vascular Devices Share (%), By Region, By Value, 2017-2027

List of Tables

Table: Global Peripheral Vascular Devices Size, By Device Type, By Value, 2017-2027

Table: Global Peripheral Vascular Devices Size, By Region, By Value (USD Million), 2017-2027

Table: North America Peripheral Vascular Devices Size, By Device Type, By Value (USD Million), 2017-2027

Table: North America Peripheral Vascular Devices Size, By Country, By Value (USD Million), 2017-2027

Table: Europe Peripheral Vascular Devices Size, By Device Type, By Value (USD Million), 2017-2027

Table: Europe Peripheral Vascular Devices Size, By Country, By Value (USD Million), 2017-2027

Table: the Asia-Pacific Peripheral Vascular Devices Size, By Device Type, By Value (USD Million), 2017-2027

Table: the Asia-Pacific Peripheral Vascular Devices Size, By Country, By Value (USD Million), 2017-2027

Table: Latin America Peripheral Vascular Devices Size, By Device Type, By Value (USD Million), 2017-2027

Table: Latin America Peripheral Vascular Devices Size, By Country, By Value (USD Million), 2017-2027

Table: The Middle-East & Africa Peripheral Vascular Devices Size, By Device Type, By Value (USD Million), 2017-2027

Table: The Middle-East & Africa Peripheral Vascular Devices Size, By Country, By Value (USD Million), 2017-2027

Table: Edward Lifesciences Corporation Financial Analysis

Table: Edward Lifesciences Corporation Business Overview

Table: Medtronic Inc. Financial Analysis

Table: Medtronic Inc. Business Overview

Table: Abbott Laboratories Financial Analysis

Table: Abbott Laboratories Business Overview

Table: Jude Medical Financial Analysis

Table: Jude Medical Business Overview

Table: Angioscore Inc. Financial Analysis

Table: Angioscore Inc. Business Overview

Table: Teleflex Medical Financial Analysis

Table: Teleflex Medical Business Overview

Table: Cook Group Inc. Financial Analysis

Table: Cook Group Inc. Business Overview

Table: Cordis Corporation Financial Analysis

Table: Cordis Corporation Business Overview

Table: Volcano Corporation Financial Analysis

Table: Volcano Corporation Business Overview

Table: Boston Scientific Corporation Financial Analysis

Table: Boston Scientific Corporation Business Overview

Table: Endologix Financial Analysis

Table: Endologix Financial Analysis

Table: Bayer Financial Analysis

Table: Bayer Business Overview

Table: Terumo Interventional Systems Inc. Financial Analysis

Table: Terumo Interventional Systems Inc. Business Overview

Table: C.R.Bard Financial Analysis

Table: C.R.Bard Business Overview

Table: Terumo Corporation Financial Analysis

Table: Terumo Corporation Business Overview

Table: Biosensors International Group Financial Analysis

Table: Biosensors International Group Business Overview

Table: iVascular Financial Analysis

Table: iVascular Business Overview

Table: Cardinal Health Financial Analysis

Table: Cardinal Health Business Overview

Table: Becton, Dickinson, and Company Financial Analysis

Table: Becton, Dickinson, and Company Business Overview